华夏国证疫苗与生物科技指数发起A(016355)资产配置
序号 |
报告期 |
股票占净比(%) |
债券占净比(%) |
现金占净比(%) |
净资产(元) |
1 |
2025-06-30 |
94.56 |
- |
6.21 |
73,538,283.24 |
2 |
2025-03-31 |
94.52 |
- |
6.10 |
74,568,034.93 |
3 |
2024-12-31 |
94.55 |
- |
6.01 |
68,479,761.97 |
4 |
2024-09-30 |
94.70 |
- |
6.06 |
79,334,451.11 |
5 |
2024-06-30 |
94.44 |
- |
6.53 |
69,405,445.67 |
6 |
2024-03-31 |
94.55 |
- |
6.42 |
74,656,349.76 |
7 |
2023-12-31 |
94.61 |
- |
5.91 |
122,021,138.79 |
8 |
2023-09-30 |
94.67 |
- |
6.06 |
119,372,346.17 |
9 |
2023-06-30 |
94.78 |
- |
5.60 |
120,532,507.69 |
10 |
2023-03-31 |
94.70 |
- |
6.30 |
128,866,849.13 |
11 |
2022-12-31 |
94.74 |
- |
6.67 |
106,765,602.01 |